Whitehawk Therapeutics, Inc.
WHWK· Nasdaq
Released Aug 7, 2025, before the open
10-Q filed Aug 7, 2025, 38 days after period end · 0000950170-25-105081
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $0.00 | $6.18M | $6.20M | $3.44M |
| Net Income | -$52.62M | -$14.58M | -$17.97M | -$18.27M |
| EPS Diluted |
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
| -$0.76 |
| -$0.54 |
| -$0.67 |
| -$0.87 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.